2022 - Research.com Best Female Scientist Award
2019 - Fellow of the Royal Society of Canada Academy of Science
Ann F. Chambers spends much of her time researching Cancer research, Metastasis, Osteopontin, Cancer cell and Cancer. Her Cancer research research is multidisciplinary, incorporating perspectives in Cell culture, Transfection, Cell, Cell growth and Signal transduction. The concepts of her Metastasis study are interwoven with issues in Immunology, Extravasation, Pathology, Tumor progression and In vivo.
The study incorporates disciplines such as Primary tumor, Lung and Mammary gland in addition to Pathology. Her biological study spans a wide range of topics, including Integrin, Cell migration and Northern blot. Ann F. Chambers has researched Cancer cell in several fields, including Alpha, Stroma, Transcellular Cell Migration and Cell division.
Her primary areas of investigation include Metastasis, Cancer research, Pathology, Osteopontin and Cancer. Her work carried out in the field of Metastasis brings together such families of science as Cancer cell, Oncology and In vivo. Ann F. Chambers combines subjects such as Immunology, Cell culture, Cell and Tumor progression with her study of Cancer research.
Her Pathology research incorporates themes from Breast cancer, Magnetic resonance imaging, Melanoma and Brain metastasis. Her research investigates the link between Osteopontin and topics such as Molecular biology that cross with problems in 3T3 cells and Monoclonal antibody. The various areas that Ann F. Chambers examines in her Cancer study include Cell growth and Bioinformatics.
Her scientific interests lie mostly in Cancer research, Pathology, Breast cancer, Oncology and Internal medicine. Her Cancer research research integrates issues from Cell culture, Cell, Cancer cell, Metastasis and Extravasation. Her studies deal with areas such as Melanoma and Cell growth as well as Metastasis.
She has included themes like Cancer, Prostate cancer and Tumor progression in her Pathology study. Her Cancer research includes elements of Angiogenesis, Disease, Immunology and Cisplatin. Her Oncology research focuses on Osteopontin and how it connects with Pleomorphic adenoma, CD44 and Adenocarcinoma.
Cancer research, Breast cancer, Metastasis, Cancer cell and Pathology are her primary areas of study. Her Cancer research research is multidisciplinary, incorporating elements of Cell culture, Cell, Cell growth, Ductal carcinoma and Extravasation. Her Breast cancer study deals with the bigger picture of Internal medicine.
Her work on Biopsy as part of general Pathology research is frequently linked to Extracellular vesicle, bridging the gap between disciplines. The various areas that she examines in her Oncology study include Prostatectomy, Prostate, Osteopontin, Hazard ratio and Radiation therapy. She has researched Osteopontin in several fields, including Cancer-Associated Fibroblasts, Tumor progression and Primary tumor.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Dissemination and growth of cancer cells in metastatic sites
Ann F. Chambers;Alan C. Groom;Ian C. MacDonald.
Nature Reviews Cancer (2002)
Changing Views of the Role of Matrix Metalloproteinases in Metastasis
Ann F. Chambers;Lynn M. Matrisian.
Journal of the National Cancer Institute (1997)
Multistep Nature of Metastatic Inefficiency: Dormancy of Solitary Cells after Successful Extravasation and Limited Survival of Early Micrometastases
Keith J. Luzzi;Ian C. MacDonald;Eric E. Schmidt;Nancy Kerkvliet.
American Journal of Pathology (1998)
Inhibition of human breast cancer cell proliferation and delay of mammary tumorigenesis by flavonoids and citrus juices
Felicia V. So;Najla Guthrie;Ann F. Chambers;Madeleine Moussa.
Nutrition and Cancer (1996)
Role of osteopontin in tumour progression
S R Rittling;A F Chambers.
British Journal of Cancer (2004)
Correlation of osteopontin protein expression and pathological stage across a wide variety of tumor histologies
Domenico Coppola;Marianna Szabo;David Boulware;Patrick Muraca.
Clinical Cancer Research (2004)
Osteopontin identified as lead marker of colon cancer progression, using pooled Sample expression profiling
Deepak Agrawal;Tingan Chen;Rosalyn Irby;John Quackenbush.
Journal of the National Cancer Institute (2002)
Temporal Progression of Metastasis in Lung: Cell Survival, Dormancy, and Location Dependence of Metastatic Inefficiency
M D Cameron;E E Schmidt;N Kerkvliet;K V Nadkarni.
Cancer Research (2000)
CD44 Variants but not CD44s Cooperate with β1-containing Integrins to Permit Cells to Bind to Osteopontin Independently of Arginine-glycine-aspartic Acid, thereby Stimulating Cell Motility and Chemotaxis
Yohko U. Katagiri;Jonathan Sleeman;Hideki Fujii;Peter Herrlich.
Cancer Research (1999)
Persistence of Solitary Mammary Carcinoma Cells in a Secondary Site: A Possible Contributor to Dormancy
George N Naumov;Ian C MacDonald;Pascal M Weinmeister;Nancy Kerkvliet.
Cancer Research (2002)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: